{"filing":{"accession_number":"0001193125-26-241940","cik":"0000728387","ticker":"CATX","company_name":"Perspective Therapeutics, Inc.","form":"8-K","filing_date":"2026-05-27","report_date":null,"primary_document":"catx-20260527.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/728387/000119312526241940/catx-20260527.htm"},"events":[{"id":8759,"run_id":7687,"accession_number":"0001193125-26-241940","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on May 27, 2026, covering three proposals: election of six directors, ratification of the independent auditor (WithumSmith+Brown, PC), and an advisory vote on compensation vote frequency. The filing presents final vote tallies for each proposal, which is the core content of Item 5.07 disclosures.","company_name":"Perspective Therapeutics, Inc.","ticker":"CATX","filing_date":"2026-05-27","form":"8-K","submitted_at":null,"items":[{"id":1942,"accession_number":"0001193125-26-241940","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on May 27, 2026, covering three proposals: election of six directors, ratification of the independent auditor (WithumSmith+Brown, PC), and an advisory vote on compensation vote frequency. The filing presents final vote tallies for each proposal, which is the core content of Item 5.07 disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:17:05.963546+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1942,"accession_number":"0001193125-26-241940","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on May 27, 2026, covering three proposals: election of six directors, ratification of the independent auditor (WithumSmith+Brown, PC), and an advisory vote on compensation vote frequency. The filing presents final vote tallies for each proposal, which is the core content of Item 5.07 disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:17:05.963546+00:00","company_name":"Perspective Therapeutics, Inc.","ticker":"CATX","filing_date":"2026-05-27"}]}